Common Stock |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| Common Stock | Common Stock The Company has a share repurchase program authorized by the Board of Directors. In November 2025, the Board of Directors of the Company authorized the Company to repurchase up to $6 billion of the Company’s common stock, which superseded any prior authorizations. In 2025, the Company repurchased 10.1 million shares of its common stock for $2.0 billion. At December 31, 2025, the Company remained authorized to repurchase up to approximately $5.7 billion in shares of its common stock. There is no time limit on the authorization. In 2024, the Company repurchased 4.3 million shares of its common stock for $900 million. The Company issued approximately 3.5 million and 3.7 million shares related to stock compensation and employee stock purchase plans for the years ended December 31, 2025 and 2024, respectively. In January 2026, the Board of Directors of the Company declared a quarterly dividend of $0.900 per share on outstanding common stock, payable in February 2026. |